Pennant Group (NASDAQ: PNTG) revenue
Pennant Group reported revenue of $947.7m for fiscal 2025, 36.3% more than in fiscal 2024 ($695.2m). Since fiscal 2018 its revenue has grown by 231.3%, an average growth of 18.7% a year.
Pennant Group has grown its revenue for 7 years in a row, and fiscal 2025 is the highest of its 8 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $947.7m | +36.3% | $51.9m | 5.5% |
| 2024 | $695.2m | +27.6% | $38.1m | 5.5% |
| 2023 | $544.9m | +15.1% | $25.2m | 4.6% |
| 2022 | $473.2m | +7.6% | $12.7m | 2.7% |
| 2021 | $439.7m | +12.5% | $4.7m | 1.1% |
| 2020 | $391.0m | +15.5% | $18.9m | 4.8% |
| 2019 | $338.5m | +18.3% | $5.7m | 1.7% |
| 2018 | $286.1m | — | $20.6m | 7.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Pennant Group revenue compared with its sector
By revenue for its latest fiscal year, Pennant Group ranks 153rd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Pennant Group, 36.3%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 151st | Claritev | $965.4m | 3.7% |
| 152nd | Madrigal Pharmaceuticals | $958.4m | 432.1% |
| 153rd | Pennant Group | $947.7m | 36.3% |
| 154th | Ionis Pharmaceuticals | $943.7m | 33.8% |
| 155th | Tilray Brands | $915.5m | 11.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Pennant Group
- How much revenue did Pennant Group make in fiscal 2025?
- Pennant Group reported revenue of $947.7m for fiscal 2025, compared with $695.2m in fiscal 2024.
- How much has the revenue of Pennant Group grown?
- Between fiscal 2018 and fiscal 2025 it went from $286.1m to $947.7m: 231.3% more, an average growth of 18.7% a year.
- What was the best year for revenue at Pennant Group?
- Of its last 8 fiscal years, fiscal 2025, with $947.7m.
- Where does Pennant Group rank in its sector by revenue?
- It ranks 153rd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Pennant Group come from?
- From the annual report (Form 10-K) that Pennant Group files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Pennant Group files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Pennant Group: the Pennant Group page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.